02.08.2012
- Cardinal Health said on Thursday its fiscal fourth-quarter earnings rose 16.4%, driven by strong sales of generic drugs, winning new customers and increased business with existing...
04.05.2012
- Cardinal Health reported higher-than-expected quarterly earnings on Thursday as strength in its pharmaceutical business offset weakness in its much smaller medical products...
10.04.2012
- Cardinal Health has named a former longtime Johnson & Johnson executive as the new head for its $9 billion medical products and services business, the U.S. pharmaceutical...
